EA200702486A1 - Противовирусная, противоопухолевая или противопаразитарная фармацевтическая композиция и ее применение - Google Patents

Противовирусная, противоопухолевая или противопаразитарная фармацевтическая композиция и ее применение

Info

Publication number
EA200702486A1
EA200702486A1 EA200702486A EA200702486A EA200702486A1 EA 200702486 A1 EA200702486 A1 EA 200702486A1 EA 200702486 A EA200702486 A EA 200702486A EA 200702486 A EA200702486 A EA 200702486A EA 200702486 A1 EA200702486 A1 EA 200702486A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
tumor
virus
application
parasitic
Prior art date
Application number
EA200702486A
Other languages
English (en)
Other versions
EA015168B1 (ru
Inventor
Аднан Реммаль
Original Assignee
Адванст Сайентифик Дивелопментс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адванст Сайентифик Дивелопментс filed Critical Адванст Сайентифик Дивелопментс
Publication of EA200702486A1 publication Critical patent/EA200702486A1/ru
Publication of EA015168B1 publication Critical patent/EA015168B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к фармацевтической композиции, содержащей по меньшей мере одно первое терапевтически активное вещество, выбранное среди карвеола, тимола, эвгенола, борнеола, карвакрола, альфа-ионона и бета-ионона, а также изомеров, производных и их смесей, и содержащей по меньшей мере одно второе терапевтически активное вещество, которое представляет собой противоопухолевый агент. Изобретение применяется в области фармацевтических препаратов.
EA200702486A 2005-05-13 2006-05-15 Противоопухолевая фармацевтическая композиция и ее применение EA015168B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001314 WO2006120495A1 (fr) 2005-05-13 2005-05-13 Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
PCT/IB2006/001328 WO2006120564A1 (fr) 2005-05-13 2006-05-15 Composition pharmaceutique comprenant un antiviral , un antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol , le thymol, l' eugenol, le borneol et le carvacrol

Publications (2)

Publication Number Publication Date
EA200702486A1 true EA200702486A1 (ru) 2008-06-30
EA015168B1 EA015168B1 (ru) 2011-06-30

Family

ID=35427309

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702486A EA015168B1 (ru) 2005-05-13 2006-05-15 Противоопухолевая фармацевтическая композиция и ее применение

Country Status (16)

Country Link
US (2) US20080171768A1 (ru)
EP (2) EP1883452B1 (ru)
JP (1) JP5073651B2 (ru)
CN (2) CN101193682B (ru)
AP (1) AP2437A (ru)
AT (1) ATE554827T1 (ru)
BR (2) BRPI0610130A2 (ru)
CA (2) CA2606887C (ru)
DK (2) DK1883452T3 (ru)
EA (1) EA015168B1 (ru)
ES (2) ES2386292T3 (ru)
MA (2) MA29573B1 (ru)
PT (2) PT1883452E (ru)
TN (2) TNSN07423A1 (ru)
WO (3) WO2006120495A1 (ru)
ZA (1) ZA200710785B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
EA019746B1 (ru) 2009-09-24 2014-05-30 Юнилевер Нв Противомикробная композиция, содержащая эвгенол, терпинеол и тимол, и способ дезинфицирования поверхности
EA022986B1 (ru) 2010-12-07 2016-04-29 Юнилевер Нв Композиция для ухода за полостью рта
CN103998011B (zh) 2011-11-03 2016-11-23 荷兰联合利华有限公司 个人清洁组合物
CN102579449B (zh) * 2012-03-30 2013-08-07 厦门大学 一种可提高肿瘤对紫杉醇敏感性的联合用药
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
US20180078515A1 (en) * 2015-03-20 2018-03-22 Sammy Oyoo OPIYO Use of suramin and arginase inhibitors in malignant neoplasia
WO2016196653A1 (en) 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
CN105147647A (zh) * 2015-08-19 2015-12-16 华南理工大学 右旋龙脑作为抗肿瘤药物增敏剂的应用
JP7033586B2 (ja) 2016-06-02 2022-03-10 アドバンスト サイエンティフィック ディヴェロップメンツ シネオールとアモキシシリンとを含む医薬製剤
BR112019020225A2 (pt) * 2017-03-28 2020-04-22 IRP Health Pty Ltd alcaloides berberina na prevenção e/ou tratamento de doença intestinal
CN112972437B (zh) * 2021-02-19 2022-03-25 沈阳伟嘉生物技术有限公司 一种包含碘硝酚的长效外用制剂及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE19509697A1 (de) * 1995-03-08 1996-09-12 Schering Ag Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2000033858A1 (en) * 1998-12-07 2000-06-15 Ecosmart Technologies, Inc. Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
US6536268B1 (en) * 1999-11-01 2003-03-25 Siemens Vdo Automotive Corporation Utilizing increasing width for identification voltages
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
AU2002227913B2 (en) * 2000-11-09 2007-08-02 Jorg P. Schur Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
US20040092583A1 (en) * 2001-01-02 2004-05-13 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
ATE478684T1 (de) * 2002-02-20 2010-09-15 Ninkov Dusan Dr Antimikrobielle therapeutische zusammensetzungen und ihre verwendung
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004052308A2 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物

Also Published As

Publication number Publication date
EP1879656A1 (fr) 2008-01-23
CA2606887A1 (fr) 2006-11-16
US20080171768A1 (en) 2008-07-17
ZA200710785B (en) 2009-06-24
PT1879656E (pt) 2012-07-25
TNSN07426A1 (fr) 2009-03-17
DK1879656T3 (da) 2012-07-23
CA2608061A1 (fr) 2006-11-16
JP2008540505A (ja) 2008-11-20
DK1883452T3 (da) 2013-02-25
CN101193682A (zh) 2008-06-04
ATE554827T1 (de) 2012-05-15
CA2608061C (fr) 2014-07-15
TNSN07423A1 (fr) 2009-03-17
JP5073651B2 (ja) 2012-11-14
CN101193682B (zh) 2012-06-13
EA015168B1 (ru) 2011-06-30
ES2399348T3 (es) 2013-03-27
EP1883452A2 (fr) 2008-02-06
WO2006120564A1 (fr) 2006-11-16
CA2606887C (fr) 2014-07-15
MA29573B1 (fr) 2008-06-02
WO2006120568A3 (fr) 2007-08-23
CN101175532B (zh) 2011-12-28
BRPI0610130A2 (pt) 2012-09-25
ES2386292T3 (es) 2012-08-16
AP2437A (en) 2012-08-31
PT1883452E (pt) 2013-02-18
EP1879656B1 (fr) 2012-04-25
EP1883452B1 (fr) 2012-12-19
CN101175532A (zh) 2008-05-07
BRPI0610123A2 (pt) 2012-09-25
MA29908B1 (fr) 2008-11-03
AP2007004228A0 (en) 2007-12-31
WO2006120495A1 (fr) 2006-11-16
US20080171709A1 (en) 2008-07-17
WO2006120568A2 (fr) 2006-11-16

Similar Documents

Publication Publication Date Title
EA200702486A1 (ru) Противовирусная, противоопухолевая или противопаразитарная фармацевтическая композиция и ее применение
EA200702483A1 (ru) Фармацевтическая композиция и её применение
EA200702482A1 (ru) Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола
ATE534383T1 (de) Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
ECSP099403A (es) Formulacion parenteral del anticuerpo abeta
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
BRPI0513622A (pt) aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
CL2011000867A1 (es) Formas cristalinas da, c y ii de (r)-5-[3-cloro-4-(2,3-dihidroxi-propoxi)- benz[z]ilideno]-2- ([z]- propilimino) -3-o- totil-tiazolidin-4-ona; composicion farmaceutica; y uso en el tratamiento o prevencion de rechazo de organos trasplantados, sindrome autoinmunitarios, asma, diabetes, cancer.
ECSP034869A (es) Una composicion para la piel, permeable selectiva inhibidora de ciclooxigenasa-2
PE20091394A1 (es) Un compuesto de alfa-(n-sulfonamido) acetamida con un inhibidor de produccion de peptido beta amiloide
CL2004000849A1 (es) Compuestos derivados de benzamidas-2-hidroxi-3-diaminoalcanos, utiles para el tratamiento o la prevencion de alzheimer, sindrome de down, hemorragia cerebral hereditaria, demencias degenerativas y otras.
NO20043367L (no) Oralt farmasoytisk preparat
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
DK1888074T3 (da) Middel til forebyggelsen og behandling af leversygdomme indeholdende pyrazolopyrimidinderivat
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
MA27669A1 (fr) Formulations topiques stabilisees contenant du ketoprofene
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
HN2004000526A (es) Hormonas de administracion transdermica que no necesitan potenciadores de penetracion
SE0203817D0 (sv) New composition
TH75845A (th) สารประกอบควิโนลิโนน-คาร์บอกแซมีดในฐานะเป็นแอกอนิสท์ของตัวรับ 5-ht4
TH87271B (th) สารผสมยา

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU